Gastroenterology
Advertisement
Strict neurologic criteria were applied to the researcher's search strategy.
Definitions and stratifications comprised the name of measurement index and the score or range of scores used.
Upadacitinib (Rinvoq) therapy yields favorable outcomes in people with Crohn disease (CD).
Patients with ulcerative colitis taking tofacitinib or biologics do not have an increased risk of MI or stroke.
The biosimilars were as effective in treating inflammatory bowel disease.
Researchers have identified a genetic variant that may help predict the development of severe ulcerative colitis.
Hurricane Healthcare Hell: Helene, Milton Cause US Government to Scramble to Find Hospital IV Fluids
The devastation caused by hurricanes Helene and Milton are significantly impacting the United States healthcare system.
A new survey showed that 40% of IBD patients have had to make significant financial sacrifices to afford health care.
Individuals with IBD have a higher risk of developing pulmonary diseases such as COPD and asthma.
Researchers have discovered that Crohn disease is comprised of two distinct molecular subtypes.
A novel landmark study has uncovered crucial insights into how antibiotic use increases the risk of IBD.
A new study found that the disease burden of patients with ulcerative colitis is high.
The success of FMT of UC is linked with specific microbiota families.
A study uncovered several potential biomarkers of UC, which may help better describe the disease's underlying mechanisms.
Patients with inflammatory bowel disease have a significantly higher risk of developing atrial fibrillation.
Researchers developed a machine learning model that can distinguish between CD and ITB, which share many clinical features.
A recent study analyzed the association between race/ethnicity and insurance status with outcomes in patients with UC.
A recent study showed no significant causal relationship between 7 lipid factors and the risk of developing IBD.
New research may explain recurrent Crohn disease in children, and it may open the door for novel treatments.
Larry Kosinski, MD, of SonarMD, discusses drivers of medical costs in people living with IBD.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.